Geraldine Henwood, President and CEO at Recro Pharma, Inc. (REPH), sold 166,112 shares at $8.89 ($1.5M) on 2019-05-13, disclosed to the SEC on 2019-05-15.
Open-market sale of $1.5M REPH by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.89 | 21,306 | $189K | 12.8% |
| 2 | $8.89 | 21,306 | $189K | 12.8% |
| 3 | $8.89 | 123,500 | $1.1M | 74.3% |
| Total | $8.89 avg | 166,112 | $1.5M | 100% |
| Filing → |
| BXRX | BUY | 2021-05-10 | $5K | — | Filing → |
| REPH | SELL | 2020-04-20 | $658K | — | Filing → |
| REPH | BUY | 2015-06-09 | $40K | — | Filing → |